Schizophrenia
📧 Sign up to get email alerts when something new happens for Schizophrenia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-06-18Clinical Trial Update: Impact of Cognitive & Metacognitive Performance on Knowledge Learning When Conducting Therapeutic Education Programs [NA]
Completed clinical trial examining how cognitive and metacognitive performance influences knowledge learning during therapeutic education pr…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II) [Phase 2]
Phase 2 GRATITUDE II trial evaluating miricorilant for antipsychotic-induced weight gain in obese adults with schizophrenia; results have be…
-
CLINICAL_TRIALS trial_result · 2024-06-13Clinical Trial Update: The Effects of tDCS on the Neuronal Mechanisms of Cognitive Control in Schizophrenia [NA]
Terminated clinical trial examining the effects of transcranial direct current stimulation on cognitive control mechanisms in schizophrenia;…
-
CLINICAL_TRIALS trial_result · 2024-06-12Clinical Trial Update: An Open-label Study to Assess the Long-term Safety, Tolerability, Effectiveness, and Durability of Effect of KarXT in Patients With DSM-5 Diagnosis of Schizophrenia [Phase 3]
Open-label Phase 3 study of KarXT in schizophrenia was terminated; results were posted on 2024-06-12.
-
CLINICAL_TRIALS trial_result · 2024-06-04Clinical Trial Update: A Neurofeedback Intervention to Improve Working Memory in Schizophrenia [NA]
A completed UC San Diego trial evaluated neurofeedback as a method to improve working memory in individuals with schizophrenia.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia [Phase 2, Phase 3]
The document reports the termination of a Phase 2/3 clinical trial evaluating AVP-786 for the treatment of negative symptoms in schizophreni…
-
CLINICAL_TRIALS trial_result · 2024-05-24Clinical Trial Update: Study to Evaluate Safety & Efficacy of NaBen® as Add-on Treatment for Schizophrenia in Adults [Phase 2, Phase 3]
A Phase 2/Phase 3 study evaluating NaBen as an add-on treatment for schizophrenia in adults has been terminated.
-
CLINICAL_TRIALS trial_result · 2024-05-23Clinical Trial Update: Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum Disorders [NA]
A clinical trial is evaluating whether combining MCT with CR improves recovery in patients with psychotic spectrum disorders; the study is c…
-
CLINICAL_TRIALS trial_result · 2024-05-17Clinical Trial Update: Brain Stimulation, Clinical Symptoms and Cognition [NA]
A brain stimulation clinical trial for schizophrenia conducted by UC Davis has completed.
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Brain Stimulation and Cognitive Training - Efficacy [NA]
This clinical trial update reports efficacy results for a brain stimulation and cognitive training intervention in schizophrenia, schizoaffe…
-
CLINICAL_TRIALS trial_result · 2024-05-09Clinical Trial Update: Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic Disorders [NA]
The completed clinical trial evaluated the efficacy of prebiotic and probiotic dietary modulation in schizophrenia, sponsored by Universidad…
-
CLINICAL_TRIALS trial_result · 2024-05-06Clinical Trial Update: Biomarkers of Conversion Risk and Treatment Response in Early-Stage Schizophrenia [Phase 4]
Phase 4 trial investigating biomarkers for conversion risk and treatment response in early-stage schizophrenia has completed with results po…
-
CLINICAL_TRIALS trial_result · 2024-05-02Clinical Trial Update: Impact of Inflammation on Reward Circuits, Motivational Deficits and Negative Symptoms in Schizophrenia [NA]
This completed clinical trial investigated the role of inflammation in reward circuits and motivational/negative symptoms in people with sch…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: Evaluation of Tolcapone as a Cognitive Enhancer in Schizophrenia [Phase 2]
This document reports on a Phase 2 clinical trial evaluating tolcapone as a cognitive enhancer in schizophrenia.
-
CLINICAL_TRIALS trial_result · 2024-04-26Clinical Trial Update: Neural Oscillations as Genetic and Functional Biomarkers in Normal and Disease States
Completed clinical trial investigating neural oscillations as genetic and functional biomarkers across normal and disease states, including …
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Raloxifene as an Adjuvant Treatment of the Negative Symptoms of Schizophrenia in Post-menopausal Women [Phase 3]
Phase 3 clinical trial evaluating raloxifene as an adjuvant treatment for negative symptoms in post-menopausal women with schizophrenia has …
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: The Safety and Efficacy of Lurasidone In Subjects With Schizophrenia Switched From Olanzapine [Phase 4]
A Phase 4 clinical trial evaluating the safety and efficacy of lurasidone in schizophrenia patients who were switched from olanzapine has be…
-
CLINICAL_TRIALS trial_result · 2024-04-19Clinical Trial Update: Study of Systemic and Ocular Safety and Pharmacokinetics of BI 409306 in Patients With Schizophrenia, Alzheimer's Disease, and Healthy Volunteers [Phase 1]
Phase 1 study assessing systemic and ocular safety and pharmacokinetics of BI 409306 in schizophrenia, Alzheimer's disease, and healthy volu…
-
CLINICAL_TRIALS trial_result · 2024-04-18Clinical Trial Update: The Safety and Efficacy of Lurasidone With Different Initiation Dose in Chinese Acute Phase Patients With Schizophrenia [Phase 4]
A Phase 4 trial evaluating safety and efficacy of lurasidone with different initiation doses in Chinese patients with schizophrenia has comp…
-
CLINICAL_TRIALS trial_result · 2024-04-15Clinical Trial Update: Neurotransmitters in Treatment Resistant Schizophrenia Patients With add-on Sodium Benzoate [Phase 2]
Phase 2 clinical trial evaluating add-on sodium benzoate for treatment-resistant schizophrenia, focusing on symptom and cognitive outcomes.
-
CLINICAL_TRIALS trial_result · 2024-04-10Clinical Trial Update: A Clinical Trial to Evaluate Safety, Tolerance and Pharmacokinetics of JX11502MA Capsule in Patients With Schizophrenia. [Phase 1, Phase 2]
A clinical trial evaluating safety, tolerance, and pharmacokinetics of JX11502MA capsule in schizophrenia has completed Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2024-04-08Clinical Trial Update: An Open-Label, Single Arm Study of the Efficacy of Accelerated Intermittent Theta Burst Stimulation in Schizophrenia Patients With Persistent Negative Symptoms [Phase 3]
A Phase 3 open-label, single-arm trial assessing accelerated intermittent theta burst stimulation for persistent negative symptoms in schizo…
-
CLINICAL_TRIALS trial_result · 2024-03-28Clinical Trial Update: Antidepressant Controlled Trial for Negative Symptoms in Schizophrenia [Phase 4]
Phase 4 clinical trial update for an antidepressant targeting negative symptoms in schizophrenia has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-15Clinical Trial Update: A Clinical Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic People With Schizophrenia, Followed by an Open-label Extension Phase [Phase 2, Phase 3]
Clinical trial evaluating SEP-363856 in acutely psychotic schizophrenia patients, with an open-label extension; study terminated.
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: Safety and Tolerability of BI 409306 in Patients With Schizophrenia [Phase 1]
This Phase 1 trial assessed the safety and tolerability of BI 409306 in patients with schizophrenia. Results have been posted following stud…